5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with cholesteryl sulfate in 1 studies
Studies (5-(tetradecyloxy)-2-furancarboxylic acid) | Trials (5-(tetradecyloxy)-2-furancarboxylic acid) | Recent Studies (post-2010) (5-(tetradecyloxy)-2-furancarboxylic acid) | Studies (cholesteryl sulfate) | Trials (cholesteryl sulfate) | Recent Studies (post-2010) (cholesteryl sulfate) |
---|---|---|---|---|---|
51 | 0 | 16 | 301 | 2 | 78 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elias, PM; Feingold, KR; Gao, WN; Guy, RH; Thornfeldt, CR; Tsai, JC | 1 |
1 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and cholesteryl sulfate
Article | Year |
---|---|
Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
Topics: Acetone; Administration, Cutaneous; Animals; Anticholesteremic Agents; Chemical Phenomena; Chemistry, Physical; Cholesterol; Cholesterol Esters; Fatty Acids; Fatty Acids, Monounsaturated; Fluvastatin; Furans; Hypolipidemic Agents; Indoles; Lidocaine; Male; Mice; Mice, Hairless; Permeability; Skin; Skin Absorption | 1996 |